374 related articles for article (PubMed ID: 27312690)
1. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.
Taj-Aldeen SJ; Salah H; Al-Hatmi AM; Hamed M; Theelen B; van Diepeningen AD; Boekhout T; Lass-Flörl C
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):438-43. PubMed ID: 27312690
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological aspects and characterization of the resistance profile of
Rosa PDD; Ramirez-Castrillon M; Borges R; Aquino V; Meneghello Fuentefria A; Zubaran Goldani L
J Med Microbiol; 2019 Oct; 68(10):1489-1496. PubMed ID: 31419209
[No Abstract] [Full Text] [Related]
3.
Oliveira Dos Santos C; Kolwijck E; van der Lee HA; Tehupeiory-Kooreman MC; Al-Hatmi AMS; Matayan E; Burton MJ; Eggink CA; Verweij PE
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182529
[TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.
Al-Hatmi AM; Normand AC; Ranque S; Piarroux R; de Hoog GS; Meletiadis J; Meis JF
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795379
[TBL] [Abstract][Full Text] [Related]
5. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
Al-Hatmi AM; van Diepeningen AD; Curfs-Breuker I; de Hoog GS; Meis JF
J Antimicrob Chemother; 2015 Apr; 70(4):1068-71. PubMed ID: 25538167
[TBL] [Abstract][Full Text] [Related]
6. EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs.
Jørgensen KM; Astvad KMT; Hare RK; Arendrup MC
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784842
[TBL] [Abstract][Full Text] [Related]
7. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S
Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295
[TBL] [Abstract][Full Text] [Related]
8. In vitro antifungal susceptibility of clinical isolates of Fusarium from Colombia.
Gaviria-Rivera A; Giraldo-López A; Cano-Restrepo LE
Rev Salud Publica (Bogota); 2017; 19(6):800-805. PubMed ID: 30183834
[TBL] [Abstract][Full Text] [Related]
9. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
[TBL] [Abstract][Full Text] [Related]
11. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
[TBL] [Abstract][Full Text] [Related]
12. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.
Tortorano AM; Prigitano A; Esposto MC; Arsic Arsenijevic V; Kolarovic J; Ivanovic D; Paripovic L; Klingspor L; Nordøy I; Hamal P; Arikan Akdagli S; Ossi C; Grancini A; Cavanna C; Lo Cascio G; Scarparo C; Candoni A; Caira M; Drogari Apiranthitou M;
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951
[TBL] [Abstract][Full Text] [Related]
13. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Rosa PD; Heidrich D; Corrêa C; Scroferneker ML; Vettorato G; Fuentefria AM; Goldani LZ
Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
[TBL] [Abstract][Full Text] [Related]
14. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
[TBL] [Abstract][Full Text] [Related]
15. Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases.
Pereira GH; de Angelis DA; Brasil RA; dos Anjos Martins M; de Matos Castro e Silva D; Szeszs MW; de Souza Carvalho Melhem M
Mycopathologia; 2013 Feb; 175(1-2):107-14. PubMed ID: 23076561
[TBL] [Abstract][Full Text] [Related]
16. Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
Mukherjee PK; Chandra J; Yu C; Sun Y; Pearlman E; Ghannoum MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4450-7. PubMed ID: 22669723
[TBL] [Abstract][Full Text] [Related]
17. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
[TBL] [Abstract][Full Text] [Related]
19. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
Debourgogne A; de Hoog S; Lozniewski A; Machouart M
Eur J Clin Microbiol Infect Dis; 2012 Apr; 31(4):615-8. PubMed ID: 21744037
[No Abstract] [Full Text] [Related]
20. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
